ABBV
AbbVie Inc. · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-20
Figures on this page computed 2026-11-08 12:24 UTC
Last close
288.24USD
Market data, 2026-11-05
Weekly closes, 2025-11-07 to 2026-11-05
Over that span: +31.5%
Except where said otherwise: 10-K for 2025, filed 2026-02-20
122.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
16.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
6.9%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
29.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
2.4%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-02-20
Price is the furthest below its sector's middle: 0.10 against 0.33 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-02-20
- Sales1.35x
Its own average over 10 years, 45.17B.
- Profit0.64x
Its own average over 10 years, 6.62B.
- Free cash flow1.10x
Its own average over 10 years, 16.23B.
- Debt1.13x
Its own average over 10 years, 60.74B.
- Price2.16x
Its own average over 11 years, 133. Market data, 2026-11-05
Price is furthest from its own average, at 2.16 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 110.1 | 89.2 | 98.3 |
| 2018-12-31 | 127.8 | 95.5 | 94.8 |
| 2019-12-31 | 129.8 | 132.4 | 91.0 |
| 2020-12-31 | 178.7 | 77.5 | 102.6 |
| 2021-12-31 | 219.2 | 193.9 | 109.0 |
| 2022-12-31 | 226.4 | 198.8 | 109.0 |
| 2023-12-31 | 211.9 | 81.7 | 108.7 |
| 2024-12-31 | 219.7 | 71.9 | 108.7 |
| 2025-12-31 | 238.6 | 71.0 | 108.7 |
How sales was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
How profit was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
How shares in issue was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
Figures behind the shape
Growth
6.0%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate6.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Five-year EPS growth rate-2.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
One-year change in net income-1.2%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Returns on capital
16.1%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital16.1%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
Return on equityn/mnegative equity
Negative equity.
Net Income / Shareholders' Equity x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
Return on assets3.1%
Net Income / Total Assets x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
Margins
70.2%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin70.2%
Gross Profit / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Operating margin24.6%
Operating Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Net margin6.9%
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Free cash flow margin29.1%
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Price
122.9xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings122.9x
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
Price to bookn/a10-Q for 2025, filed 2026-11-03
We do not hold this figure for this company, so there is nothing to place.
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000037
- Reported in
- USD
- computed
- 10-Q for 2025, filed 2026-11-03
- computed
- 10-K for 2025, filed 2026-02-20
EV to EBITDA36.6x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-20
Price to sales ratio8.4x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Safety
0.67safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-03
Current ratio0.6710-Q for 2025, filed 2026-11-03
Current Assets / Current Liabilities
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000037
- Reported in
- USD
- 10-Q for 2025, filed 2026-11-03
- 10-Q for 2025, filed 2026-11-03
Interest coverage5.2x
Operating Income / Interest Expense
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Altman Z-Score2.80
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
What it pays out
2.4%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield2.4%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-02-20
Payout ratio275.8%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001551152-26-000008
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
Dividend cover ratio1.5x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.